Article Figures & Data
Tables
Appropriate patient preparation Withdrawal of T4 for 4–6 wk or of T3 for 2 wk. A strict low-iodine diet (≤50 μg iodine per day) followed for 7–14 d before 131I DWBS and continuing throughout period of imaging. Avoidance of iodine-containing medications (e.g., iodinated contrast medium, amiodarone, betadine), iodine-rich foods (e.g., kelp), and possible additives of iodine in vitamin and electrolyte supplements. TSH ≥ 30 mIU/L. A mild laxative sometimes administered on the evening before 131I DWBS to simplify image interpretation. Information relating to patient’s compliance with low-iodine diet, TSH level, history of thyroid hormone withdrawal, measurement of Tg, history of prior administration of contrast medium or iodine-containing drugs (e.g., amiodarone), menstrual history/pregnancy test, nursing/lactation history, etc. Measurement of urinary iodine in doubtful cases to rule out iodine contamination; repeated WBS 4–6 wk after iodine-depletion regimen such as diuretic program. Rule out women with pregnancy and breast feeding. T3 = triiodothyronine.
Reasons for 131I DWBS− Tg+ False-positive Tg and true-negative 131I DWBS Interference of circulating Tg Ab. Benign lesions (possibly containing thyroiditis) of persistent residual thyroid tissue or nonthyroidal tissue producing Tg. True-positive Tg and false-negative 131I DWBS Defective iodine-trapping mechanism such as acquired inactivation mutation of NIS, TPO gene, and pendrin. Dedifferentiation of tumor such that it can still produce Tg but has lost its iodine-trapping ability. Dispersed microscopic metastases too small to be visualized. Improper patient preparation before 131I DWBS such as stable iodine contamination and inadequate TSH elevation.